Compare NRG Energy Inc (NRG) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NRG Energy Inc vs TransMedics Group Inc — how do they compare? NRG Energy Inc trades at $132.3 (market cap $27.55B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: NRG Energy Inc is far larger — about 10.8× TransMedics Group Inc's market cap, and NRG Energy Inc pays a 1.46% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| NRG | TMDX | |
|---|---|---|
Market Cap | $27.55B | $2.54B |
Sector | Utilities | Technology |
52-Week High | $184.03 | $150.42 |
52-Week Low | $120.65 | $61.99 |
Enterprise Value | $51.38B | $2.94B |
Dividend Yield | 1.46% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NRG Energy Inc
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
